The Great Healthcare Debate 7 DAYS · Free panel + drinks · 12 May · London RSVP free →
Sunday 10 May 2026

One To Watch

Armetheon

Company Overview

Want to Update your Company's Profile?


Latest Armetheon News

Espero Pharmaceuticals and Armetheon to merge
31 March 2017
Lee's Pharma unit gains exclusive rights to tecarfarin in Greater China and Thailand
22 September 2015
Plans for Armetheon's anticoagulant tecarfarin for patients with prosthetic heart valves or chronic renal dysfunction
11 March 2013
More Armetheon news >


Today's issue

The week in pharma: action, reaction and insight – week to May 8, 2026
Pharmaceutical
The week in pharma: action, reaction and insight – week to May 8, 2026
10 May 2026
Biotechnology
FDA expands approval of argenx’ VyvgartFDA expands approval of argenx’ Vyvgart
9 May 2026
Biotechnology
FDA nod for Partner Therapeutics’ Bizengri
9 May 2026
Pharmaceutical
Italfarmaco’s new CEO and commitment to rare disease R&D
8 May 2026
Generics
Russia experiencing sales boom of obesity drugs
8 May 2026
Pharmaceutical
EC approves new use for BMS’ Sotyktu
8 May 2026
Biotechnology
Shares dip as Gilead adjusts to acquisition costs
8 May 2026




Copyright © The Pharma Letter 2026

 |  Headless Content Management with Blaze